The first clinical trial to test the tumour-fighting power of a stem-cell-like class of long-lived immune cells suggests that ...

New research has identified a protein that could serve as both a biomarker and therapeutic target to weaken stem-like cancer ...

Researchers are developing drugs and engineered immune cells to eliminate chemotherapy-induced senescent 'zombie' cells, which can promote inflammation and possibly cancer relapse. Preclinical studies ...

Researchers are developing nanozymes that can attack brain cancer cells directly during tumor surgery, offering new hope when ...